Breeze Meds vs Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Breeze Meds and Hers are tied at 7.3/10. Breeze Meds is more affordable at $199/mo vs $348/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Hers for women who want glp-1 access from a well-known, publicly trad.
A side-by-side comparison of Breeze Meds and Hers covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#29 of 40Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsHers
#33 of 40The women's health arm of Hims & Hers Health (NYSE: HIMS), offering compounded GLP-1 medications with a polished app experience designed for women's health needs.
Visit Hers| Feature | Breeze Meds | Hers |
|---|---|---|
| Our Score | 7.3/10 | 7.3/10 |
| Starting Price | $199/mo | $348/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Women who want GLP-1 access from a well-known, publicly traded telehealth brand |
| Ranking | #29 | #33 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Women-focused branding, content, and support — not a men's health platform with a women's tab
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Broader women's health platform — can address hormonal, skin, and wellness needs alongside weight loss
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Our Verdict
Breeze Meds and Hers are closely matched with identical scores of 7.3/10. If budget is your priority, Breeze Meds starts at $199/mo compared to Hers's $348/mo. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Hers if you want: women who want glp-1 access from a well-known, publicly traded telehealth brand.